By expenditures
| Name | Title | Type |
|---|---|---|
| Tamara Vineyard | Partner | Auditee |
| Kerrie Wilson | Chief Executive Officer | Auditee |
| Tamara Vineyard | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 368880 | 2024 | 2025-09-29 | Pbmares LLP | $10.03M |
| 316340 | 2021 | 2024-07-31 | Forvis Mazars | $9.90M |
| 316339 | 2022 | 2024-07-31 | Forvis Mazars | $10.71M |
| 316337 | 2023 | 2024-07-31 | Forvis Mazars | $10.76M |
| 33333 | 2022 | 2023-06-13 | Forvis | $9.77M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 368880 | 2024 | 2025-09-29 | 1156532 | 2024-002 | Material Weakness | Yes | AB |
| 368880 | 2024 | 2025-09-29 | 1156531 | 2024-001 | Material Weakness | Yes | E |
| 316340 | 2021 | 2024-07-31 | 1056506 | 2021-005 | Material Weakness | - | E |
| 316340 | 2021 | 2024-07-31 | 1056505 | 2021-005 | Material Weakness | - | E |
| 316340 | 2021 | 2024-07-31 | 1056504 | 2021-005 | Material Weakness | - | E |
| 316339 | 2022 | 2024-07-31 | 1056503 | 2022-005 | Significant Deficiency | - | AB |
| 316339 | 2022 | 2024-07-31 | 1056502 | 2022-004 | Significant Deficiency | - | E |
| 316339 | 2022 | 2024-07-31 | 1056501 | 2022-003 | Significant Deficiency | - | E |
| 316339 | 2022 | 2024-07-31 | 1056500 | 2022-001 | Material Weakness | - | AB |
| 316339 | 2022 | 2024-07-31 | 1056499 | 2022-007 | Material Weakness | Yes | E |
| 316339 | 2022 | 2024-07-31 | 1056498 | 2022-007 | Material Weakness | Yes | E |
| 316339 | 2022 | 2024-07-31 | 1056497 | 2022-007 | Material Weakness | Yes | E |
| 316339 | 2022 | 2024-07-31 | 1056496 | 2022-007 | Material Weakness | Yes | E |
| 316339 | 2022 | 2024-07-31 | 1056495 | 2022-007 | Material Weakness | Yes | E |
| 316339 | 2022 | 2024-07-31 | 1056494 | 2022-005 | Significant Deficiency | - | AB |
| 316339 | 2022 | 2024-07-31 | 1056493 | 2022-004 | Significant Deficiency | - | E |
| 316339 | 2022 | 2024-07-31 | 1056492 | 2022-003 | Significant Deficiency | - | E |
| 316339 | 2022 | 2024-07-31 | 1056491 | 2022-001 | Material Weakness | - | AB |
| 316337 | 2023 | 2024-07-31 | 1056490 | 2023-004 | Material Weakness | Yes | E |
| 316337 | 2023 | 2024-07-31 | 1056489 | 2023-004 | Material Weakness | Yes | E |
| 316337 | 2023 | 2024-07-31 | 1056488 | 2023-003 | Material Weakness | Yes | AB |
| 316337 | 2023 | 2024-07-31 | 1056487 | 2023-002 | Significant Deficiency | Yes | E |
| 316337 | 2023 | 2024-07-31 | 1056486 | 2023-001 | Material Weakness | Yes | AB |
| 316337 | 2023 | 2024-07-31 | 1056485 | 2023-003 | Material Weakness | Yes | AB |
| 316337 | 2023 | 2024-07-31 | 1056484 | 2023-004 | Material Weakness | Yes | E |
| 316337 | 2023 | 2024-07-31 | 1056483 | 2023-004 | Material Weakness | Yes | E |
| 316337 | 2023 | 2024-07-31 | 1056482 | 2023-004 | Material Weakness | Yes | E |
| 316337 | 2023 | 2024-07-31 | 1056481 | 2023-002 | Significant Deficiency | Yes | E |
| 316337 | 2023 | 2024-07-31 | 1056480 | 2023-001 | Material Weakness | Yes | AB |
| 316340 | 2021 | 2024-07-31 | 480064 | 2021-005 | Material Weakness | - | E |
| 316340 | 2021 | 2024-07-31 | 480063 | 2021-005 | Material Weakness | - | E |
| 316340 | 2021 | 2024-07-31 | 480062 | 2021-005 | Material Weakness | - | E |
| 316339 | 2022 | 2024-07-31 | 480061 | 2022-005 | Significant Deficiency | - | AB |
| 316339 | 2022 | 2024-07-31 | 480060 | 2022-004 | Significant Deficiency | - | E |
| 316339 | 2022 | 2024-07-31 | 480059 | 2022-003 | Significant Deficiency | - | E |
| 316339 | 2022 | 2024-07-31 | 480058 | 2022-001 | Material Weakness | - | AB |
| 316339 | 2022 | 2024-07-31 | 480057 | 2022-007 | Material Weakness | Yes | E |
| 316339 | 2022 | 2024-07-31 | 480056 | 2022-007 | Material Weakness | Yes | E |
| 316339 | 2022 | 2024-07-31 | 480055 | 2022-007 | Material Weakness | Yes | E |
| 316339 | 2022 | 2024-07-31 | 480054 | 2022-007 | Material Weakness | Yes | E |
| 316339 | 2022 | 2024-07-31 | 480053 | 2022-007 | Material Weakness | Yes | E |
| 316339 | 2022 | 2024-07-31 | 480052 | 2022-005 | Significant Deficiency | - | AB |
| 316339 | 2022 | 2024-07-31 | 480051 | 2022-004 | Significant Deficiency | - | E |
| 316339 | 2022 | 2024-07-31 | 480050 | 2022-003 | Significant Deficiency | - | E |
| 316339 | 2022 | 2024-07-31 | 480049 | 2022-001 | Material Weakness | - | AB |
| 316337 | 2023 | 2024-07-31 | 480048 | 2023-004 | Material Weakness | Yes | E |
| 316337 | 2023 | 2024-07-31 | 480047 | 2023-004 | Material Weakness | Yes | E |
| 316337 | 2023 | 2024-07-31 | 480046 | 2023-003 | Material Weakness | Yes | AB |
| 316337 | 2023 | 2024-07-31 | 480045 | 2023-002 | Significant Deficiency | Yes | E |
| 316337 | 2023 | 2024-07-31 | 480044 | 2023-001 | Material Weakness | Yes | AB |
| 316337 | 2023 | 2024-07-31 | 480043 | 2023-003 | Material Weakness | Yes | AB |
| 316337 | 2023 | 2024-07-31 | 480042 | 2023-004 | Material Weakness | Yes | E |
| 316337 | 2023 | 2024-07-31 | 480041 | 2023-004 | Material Weakness | Yes | E |
| 316337 | 2023 | 2024-07-31 | 480040 | 2023-004 | Material Weakness | Yes | E |
| 316337 | 2023 | 2024-07-31 | 480039 | 2023-002 | Significant Deficiency | Yes | E |
| 316337 | 2023 | 2024-07-31 | 480038 | 2023-001 | Material Weakness | Yes | AB |
| 33333 | 2022 | 2023-06-13 | 612026 | 2022-005 | Significant Deficiency | - | B |
| 33333 | 2022 | 2023-06-13 | 612025 | 2022-004 | Significant Deficiency | - | E |
| 33333 | 2022 | 2023-06-13 | 612024 | 2022-003 | Significant Deficiency | - | E |
| 33333 | 2022 | 2023-06-13 | 612023 | 2022-001 | Material Weakness | - | B |
| 33333 | 2022 | 2023-06-13 | 35584 | 2022-005 | Significant Deficiency | - | B |
| 33333 | 2022 | 2023-06-13 | 35583 | 2022-004 | Significant Deficiency | - | E |
| 33333 | 2022 | 2023-06-13 | 35582 | 2022-003 | Significant Deficiency | - | E |
| 33333 | 2022 | 2023-06-13 | 35581 | 2022-001 | Material Weakness | - | B |